The Valley Desk

NCT02285114 · Interventional trial

Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen

Overall registry status Completed

Phase 2 · Phase 3

Conditions HIV-1

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov